Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Clin Cancer Res. 2010 Jul 20;16(19):4742–4754. doi: 10.1158/1078-0432.CCR-10-0529

Figure 6. Co-treatment with BZ and PS inhibits in vivo tumor growth in Z138C xenografts.

Figure 6

A, Regression of tumor volume (n=8) following treatment with PS, BZ and a combination of BZ and PS is depicted. B, Kaplan-Meier survival plot for a Z138C xenograft model of MCL: NOD-SCID mice (n=8/group) were injected with Z138C cells subcutaneously and treatment with BZ, PS and the combination was commenced when the average tumor volume reached 50 mm3.

HHS Vulnerability Disclosure